Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
about
The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseAntibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote AngiogenesisEpstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required.PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas.Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.EBV-related lymphomas: new approaches to treatment.The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models.1-(2,3-Dibenzimidazol-2-ylpropyl)-2-methoxybenzene Is a Syk Inhibitor with Anti-Inflammatory Properties.Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.
P2860
Q26998401-1A38C063-8F2E-43E6-AFCE-155D2E8873D2Q34550268-50A9C722-C10C-4359-8660-69322F767DAFQ36281674-44C99151-968D-41DF-819F-4CAFE9270BCFQ38720593-203475E2-0D44-4246-97B8-46070BAE4388Q38732564-AC1523A1-C104-4622-8D59-2D3FDF48C225Q39127814-3A2B903A-5969-4F5B-B993-C6E443DBECFCQ39176686-BE041429-8603-47B6-9598-00A8311D22B2Q39441281-E88BF007-B604-43B7-9C87-164EEA0EF014Q42247976-13A83ADB-649F-4685-B5E9-BBCAB51B0FF0Q47744411-984169C0-3076-41D2-891C-119AC4F09030Q49416991-3521706A-0BAD-400A-9EED-47CFBC01B5AEQ51364204-50638682-8471-4A38-BEFA-7FB7385683C3Q52593090-64B2D89E-BD42-4048-8933-08048764D26E
P2860
Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@ast
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@en
Src kinase and Syk activation ...... rotein 1 in Epstein-Barr virus
@nl
type
label
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@ast
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@en
Src kinase and Syk activation ...... rotein 1 in Epstein-Barr virus
@nl
prefLabel
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@ast
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@en
Src kinase and Syk activation ...... rotein 1 in Epstein-Barr virus
@nl
P2093
P2860
P1433
P1476
Src kinase and Syk activation ...... virus (EBV)+ B cell lymphomas.
@en
P2093
Olivia Hatton
Olivia M Martinez
Sheri M Krams
Stacie L Lambert
P2860
P304
P356
10.1371/JOURNAL.PONE.0042610
P407
P577
2012-08-03T00:00:00Z